Patent ID: 6979682
Filing Date: 2005-12-27
Classification: A61K

Abstract:
1. A method of inhibiting the growth of a tumor in a mammal, wherein the tumor is a carcinoma of the lung or of the prostate and wherein the growth of the tumor depends on basic fibroblast growth factor-stimulated angiogenesis, said method comprising administering to the mammal a therapeutically effective amount of bFGF-active PAF antagonist tetrahydro-4,7,8,10-methyl-1-(chloro-2-phenyl)-6-(methoxy-4-phenyl-carbomoyl)-9-pyrido[4′,3′-4,5]thieno[3,2-f]triazolo-1,2,4-[4,3-a]diazepine-1,4 (BN-50730).